Literature DB >> 21513969

Induction of tolerance to parental parathyroid grafts using allogeneic thymus tissue in patients with DiGeorge anomaly.

Ivan K Chinn1, M Louise Markert.   

Abstract

DiGeorge anomaly can affect both thymic and parathyroid function. Although athymia is corrected by allogeneic thymus transplantation, treatment options for hypoparathyroidism have been unsatisfactory. Parathyroid transplantation offers the potential for definitive cure but remains challenging because of graft rejection. Some allogeneic parathyroid grafts have functioned in adult recipients in the context of immunosuppression for renal transplantation. Other efforts have attempted to reduce the allogenicity of the parathyroid grafts through manipulation of the parathyroid tissues before transplantation (by using encapsulation or special culture techniques). Recently, we demonstrated the efficacy of parental parathyroid transplantation when combined with allogeneic thymus transplantation in an infant with complete DiGeorge anomaly. The recipient developed tolerance toward the parathyroid donor. The parathyroid graft has functioned for 5 years after transplantation without the need for continued immunosuppression or calcium supplementation. We observed that matching of the allogeneic thymus graft to the parathyroid donor HLA class II alleles that are unshared with the recipient appears to be associated with the induction of tolerance toward the parathyroid graft. Further work is needed to determine the optimal means for using combined allogeneic thymus and parental parathyroid transplantation to correct hypoparathyroidism in patients with both complete and partial DiGeorge anomaly.
Copyright © 2011 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21513969      PMCID: PMC3109298          DOI: 10.1016/j.jaci.2011.03.033

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  20 in total

Review 1.  An overview on non-T cell pathways in transplant rejection and tolerance.

Authors:  Wentao Liu; Xian C Li
Journal:  Curr Opin Organ Transplant       Date:  2010-08       Impact factor: 2.640

2.  Definitive treatment for persistent hypoparathyroidism in a kidney transplant patient: parathyroid allotransplantation.

Authors:  N M Torregrosa; J M Rodríguez; S Llorente; M D Balsalobre; A Rios; L Jimeno; P Parrilla
Journal:  Thyroid       Date:  2005-11       Impact factor: 6.568

3.  Survival of macroencapsulated allogeneic parathyroid tissue one year after transplantation in nonimmunosuppressed humans.

Authors:  A Tibell; E Rafael; L Wennberg; J Nordenström; M Bergström; R L Geller; T Loudovaris; R C Johnson; J H Brauker; S Neuenfeldt; A Wernerson
Journal:  Cell Transplant       Date:  2001       Impact factor: 4.064

4.  HLA-DR matching improves survival after heart transplantation: is it time to change allocation policies?

Authors:  Ingo Kaczmarek; Marcus-Andre Deutsch; Maria-Elisabeth Rohrer; Andres Beiras-Fernandez; Jan Groetzner; Sabine Daebritz; Michael Schmoeckel; Michael Spannagl; Bruno Meiser; Bruno Reichart
Journal:  J Heart Lung Transplant       Date:  2006-08-08       Impact factor: 10.247

Review 5.  Tolerance: is it achievable in pediatric solid organ transplantation?

Authors:  Vicki Seyfert-Margolis; Sandy Feng
Journal:  Pediatr Clin North Am       Date:  2010-04       Impact factor: 3.278

6.  Long-term tolerance to allogeneic thymus transplants in complete DiGeorge anomaly.

Authors:  Ivan K Chinn; Blythe H Devlin; Yi-Ju Li; M Louise Markert
Journal:  Clin Immunol       Date:  2007-12-26       Impact factor: 3.969

7.  Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants.

Authors:  M Louise Markert; Blythe H Devlin; Marilyn J Alexieff; Jie Li; Elizabeth A McCarthy; Stephanie E Gupton; Ivan K Chinn; Laura P Hale; Thomas B Kepler; Min He; Marcella Sarzotti; Michael A Skinner; Henry E Rice; Jeffrey C Hoehner
Journal:  Blood       Date:  2007-02-06       Impact factor: 22.113

Review 8.  Chromosome 22q11.2 deletion syndrome: DiGeorge syndrome/velocardiofacial Syndrome.

Authors:  Kathleen E Sullivan
Journal:  Immunol Allergy Clin North Am       Date:  2008-05       Impact factor: 3.479

9.  Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety.

Authors:  John L Vahle; Masahiko Sato; Gerald G Long; Jamie K Young; Paul C Francis; Jeffery A Engelhardt; Michael S Westmore; Yanfei Linda; James B Nold
Journal:  Toxicol Pathol       Date:  2002 May-Jun       Impact factor: 1.902

Review 10.  The role of in vitro alloreactive T-cell functional tests in the selection of HLA matched and mismatched haematopoietic stem cell donors.

Authors:  Matjaz Jeras
Journal:  Transpl Immunol       Date:  2002-08       Impact factor: 1.708

View more
  8 in total

Review 1.  Advances in basic and clinical immunology in 2011.

Authors:  Javier Chinen; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2011-12-28       Impact factor: 10.793

Review 2.  Mechanisms of Mixed Chimerism-Based Transplant Tolerance.

Authors:  Julien Zuber; Megan Sykes
Journal:  Trends Immunol       Date:  2017-08-18       Impact factor: 16.687

Review 3.  Clinical and imaging considerations in primary immunodeficiency disorders: an update.

Authors:  Eveline Y Wu; Lauren Ehrlich; Brian Handly; Donald P Frush; Rebecca H Buckley
Journal:  Pediatr Radiol       Date:  2016-09-22

Review 4.  22q11 deletion syndrome: current perspective.

Authors:  Bülent Hacıhamdioğlu; Duygu Hacıhamdioğlu; Kenan Delil
Journal:  Appl Clin Genet       Date:  2015-05-18

Review 5.  Molecular Insights Into the Causes of Human Thymic Hypoplasia With Animal Models.

Authors:  Pratibha Bhalla; Christian A Wysocki; Nicolai S C van Oers
Journal:  Front Immunol       Date:  2020-05-05       Impact factor: 7.561

Review 6.  New allogeneic hematopoietic stem cell transplantation method: hematopoietic stem cell transplantation plus thymus transplantation for intractable diseases.

Authors:  Naoki Hosaka
Journal:  Clin Dev Immunol       Date:  2013-05-12

7.  FOXN1: A Master Regulator Gene of Thymic Epithelial Development Program.

Authors:  Rosa Romano; Loredana Palamaro; Anna Fusco; Giuliana Giardino; Vera Gallo; Luigi Del Vecchio; Claudio Pignata
Journal:  Front Immunol       Date:  2013-07-12       Impact factor: 7.561

Review 8.  Immunodeficiency in DiGeorge Syndrome and Options for Treating Cases with Complete Athymia.

Authors:  E Graham Davies
Journal:  Front Immunol       Date:  2013-10-31       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.